ArticleKorean journal of pediatrics2019

Benefits and risks of therapeutic alternatives for macrolide resistant Mycoplasma pneumoniae pneumonia in children.

Hyeon-Jong YangPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.